JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB200195

重组Anti-AKT1 + AKT2 + AKT3抗体[EPR17737]

Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737]

  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • 了解详情

Be the first to review this product! Submit a review

|

(13 Publications)

Rabbit Recombinant Monoclonal AKT1 antibody. Suitable for WB, ICC/IF and reacts with Recombinant fragment, Mouse, Rat, Human samples. Cited in 13 publications.

查看别名

PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MCF7 (Human breast adenocarcinoma cell line) cells labeling AKT1 + AKT2 + AKT3 with ab200195 at 1/1000 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green).

Cytoplasm staining on MCF7 cell line is observed.

The nuclear counter stain is DAPI (blue).

Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab200195 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/10000 dilution

Lane 1:

PC-3 (Human prostate cancer cell line) whole cell lysate at 10 µg

Lane 2:

Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 10 µg

Lane 3:

293 (Human embryonic kidney) whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 56 kDa

false

Exposure time: 30s

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution

All lanes:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

false

Exposure time: 15s

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/10000 dilution

All lanes:

HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 56 kDa

false

Exposure time: 3min

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution

Lane 1:

Human fetal brain tissue lysate at 10 µg

Lane 2:

Human fetal heart tissue lysate at 10 µg

Lane 3:

Human fetal kidney tissue lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 56 kDa

false

Exposure time: 15s

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Mouse spleen lysate at 10 µg

Lane 3:

Rat brain lysate at 10 µg

Lane 4:

Rat heart lysate at 10 µg

Lane 5:

C6 (Rat glial tumor cells) whole cell lysate at 10 µg

Lane 6:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 56 kDa

false

Exposure time: 10s

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

Supplier Data

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

AKT3 recombinant protein fragment contains aa351-479 with His-Tag®. AKT2 recombinant protein fragment contains aa282-481 with His-Tag® and AKT1 recombinant protein fragment contains aa281-480 with His-Tag®.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution

Lane 1:

AKT3 recombinant protein fragment (His-Tag®): aa351-479 at 0.01 µg

Lane 2:

AKT2 recombinant protein fragment (His-Tag®): aa282-481 at 0.01 µg

Lane 3:

AKT1 recombinant protein fragment (His-Tag®): aa281-480 at 0.01 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 56 kDa

false

Exposure time: 3s

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
  • WB

CiteAb

Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)

AKT1 + AKT2 + AKT3 western blot using anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] ab200195. Publication image and figure legend from Wang, Z., Liu, Y., et al., 2020, Oxid Med Cell Longev, PubMed 31998436.

ab200195 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab200195 please see the product overview.

Nrf2 signaling regulated by PI3K/Akt activation is involved in AM-mediated liver protection in mice with chronic alcohol injury. (a) AM and Sil increased the expression levels of P-PI3K, P-Akt, P-Stat3, Nrf2, SOD-1/2, and HO-1/2 in livers. (b) AM and Sil increased the expression levels of Nrf2 in the cytoplasm and nucleus of liver tissues. The data of quantified protein expressions were normalized by related total protein expressions, GAPDH, β-actin, and/or lamin B. The data were analyzed using one-way ANOVA and expressed as means ± S.E.M. (n = 4). ##p < 0.01 and ###p < 0.001 vs. the control group; *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the alcohol-only treated model group. AM : Aronia melanocarpa; Sil : silybin.

false

不同偶联物与剂型 (1)

  • Carrier free

    Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR17737

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

WB, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Recombinant fragment": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

AKT1 AKT2 and AKT3 also known as Protein Kinase B (PKB) isoforms are serine/threonine-specific protein kinases with critical roles in cellular processes. AKT1 has a molecular weight of about 55.8 kDa AKT2 weighs approximately 56.1 kDa and AKT3 typically has a similar mass. These proteins are expressed in many tissues including brain and heart with AKT1 ubiquitously present AKT2 focused in insulin-responsive tissues and AKT3 mainly in the brain. The molecular weight of AKT plays an important role in their functionality and specificity in tissues.
Biological function summary

AKT proteins regulate cell cycle growing cell survival proliferation and metabolism. They participate as core components of the PI3K/AKT/mTOR signaling pathway forming complexes with other proteins to transmit signals. They bind to phosphoinositide lipids on the cell membrane facilitating their activation and downstream signaling. Through these activities the AKT transporter proteins maintain cellular homeostasis and play a part in stress response.

Pathways

AKT proteins engage in important signaling networks including the PI3K/AKT pathway and mTOR pathway. They work closely with PI3K and mTOR proteins coordinating cellular growth and energy metabolism. In particular the AKT pathway responds to growth factors and insulin influencing glucose uptake and glycolysis regulation through interaction with proteins such as glycogen synthase kinase 3 (GSK3).

Dysregulation of AKT signaling can lead to cancer and diabetes. High AKT activation correlates with various cancers by promoting cell survival and growth. In diabetes impaired AKT2 regulation disrupts glucose uptake affecting insulin response. AKT's relationship with mTOR is significant as it often influences tumor growth and progression in cancerous tissues.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed : 11882383, PubMed : 15526160, PubMed : 15861136, PubMed : 21432781, PubMed : 21620960, PubMed : 31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960, PubMed : 29343641, PubMed : 31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed : 11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed : 11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed : 11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed : 12150915, PubMed : 12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed : 31548394, PubMed : 33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed : 10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed : 10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed : 10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed : 9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed : 9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed : 12176338, PubMed : 12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed : 19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its : kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed : 17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its : cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed : 20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed : 19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed : 10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed : 10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed : 23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed : 20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed : 18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed : 16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed : 16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed : 20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed : 32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors : forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed : 32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed : 30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed : 15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed : 31204173).
See full target information AKT1

其他靶点

RAC-beta serine/threonine-protein kinase,AKT3

文献 (13)

Recent publications for all applications. Explore the full list and refine your search

Nutrients 17: PubMed40077694

2025

Unraveling the Osteogenic Activity and Molecular Mechanism of an Antioxidant Collagen Peptide in MC3T3-E1 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yali Wang,Yue Wang,Xiaoyan Zhuang,Yonghui Zhang,Baishan Fang,Yousi Fu

Frontiers in pharmacology 13:898906 PubMed35662701

2022

Calf Thymus Polypeptide Restrains the Growth of Colorectal Tumor Regulating the Intestinal Microbiota-Mediated Immune Function.

Applications

Unspecified application

Species

Unspecified reactive species

Lanzhou Li,Chenfei Zhao,Fange Kong,Yi-Cong Li,Chunxia Wang,Shanshan Chen,Hor-Yue Tan,Yang Liu,Di Wang

Biological & pharmaceutical bulletin 45:143-149 PubMed34707025

2021

Neuroprotective Effects of Tetrahydroxystilbene Glucoside against Rotenone-Induced Toxicity in PC12 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ruoqiu Fu,Haiyan Xing,Xianfeng Wang,Yao Liu,Bin Li,Lin Zhang,Ziwei Li,Dongyu Duan,Jianhong Chen

Aging 13:11150-11169 PubMed33819182

2021

The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yidi Qu,Wenqi Wang,Tianrui Chen,Yumin Yang,Yizhi Zhang,Di Wang

Frontiers in oncology 11:656184 PubMed33816313

2021

Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin.

Applications

Unspecified application

Species

Unspecified reactive species

Lin Zhang,Ruoqiu Fu,Dongyu Duan,Ziwei Li,Bin Li,Yue Ming,Li Li,Rui Ni,Jianhong Chen

OncoTargets and therapy 13:12225-12241 PubMed33273828

2020

The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ziwei Li,Bin Li,Li Li,Guanying Wang,Yuanyuan Li,Ruoqiu Fu,Yue Ming,Rui Ni,Jiming Wang,George Ye,Jianhong Chen

International journal of molecular sciences 21: PubMed32784451

2020

Isoforsythiaside Attenuates Alzheimer's Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chunyue Wang,Jie Hao,Xin Liu,Chenliang Li,Xuyang Yuan,Robert J Lee,Tian Bai,Di Wang

Frontiers in microbiology 11:1113 PubMed32719658

2020

Triterpenoids Extracted From Mycelia Attenuate Acute Alcohol-Induced Liver Injury in C57BL/6 Mice Suppression Inflammatory Response.

Applications

Unspecified application

Species

Unspecified reactive species

Yange Liu,Zhuqian Wang,Fange Kong,Lesheng Teng,Xiaoyi Zheng,Xingkai Liu,Di Wang

International journal of biological macromolecules 156:204-216 PubMed32156537

2020

Calf thymus polypeptide improved hematopoiesis via regulating colony-stimulating factors in BALB/c mice with hematopoietic dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Lanzhou Li,Xue Jiang,Shanshan Teng,Luping Zhang,Lesheng Teng,Di Wang

Oxidative medicine and cellular longevity 2020:4054520 PubMed31998436

2020

Prevents Alcohol-Induced Chronic Liver Injury via Regulation of Nrf2 Signaling in C57BL/6 Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Zhuqian Wang,Yange Liu,Xuyu Zhao,Shuyan Liu,Yang Liu,Di Wang
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com